Evidence map›Paper›PMID 25261699›Full record

ArticleGlobal health action2014

Going beyond the disability-based morbidity definition in the compression of morbidity framework.

Hiram Beltrán-Sánchez, Fahad Razak, S V Subramanian

Abstract read
In one paragraph

Article in Global health action, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Rethinking morbidity compression.European journal of epidemiology · 2020
    Article
  11. Purpose in Life Among Centenarian Offspring.The journals of gerontology. Series B, Psychological sciences and social sciences · 2020
    Article
  12. Article
  13. Article
  14. Morbidity compression: a promising and well-established concept?International journal of public health · 2016
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hiram Beltrán-SánchezCenter for Demography of Health and Aging, University of Wisconsin-Madison, Madison, WI, USA.
Fahad RazakSt Michael's Hospital, University of Toronto, Toronto, Canada; Li Ka Shing Knowledge Institute, Ontario, Canada; Harvard Center for Population and Development Studies, Cambridge, MA, USA.
S V SubramanianHarvard Center for Population and Development Studies, Cambridge, MA, USA; Department of Social and Behavioral Sciences, School of Public Health, Harvard University, Boston, MA, USA; svsubram@hsph.harvard.edu.

Funding

Statistical Data Enclave CoreP30AG017266 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Michal Engelman · 1999 to 2026
$17.0M
Center for Demography and EcologyR24HD047873 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI RAYMO, JAMES M · 2004 to 2013
$7.2M
NIA NIH HHS P30 AG017266NICHD NIH HHS R24 HD047873
6 · The paper itself

Abstract

backgroundAs originally proposed by Fries, conceptualizing morbidity solely through associated functional limitation/disability (FL/D) remains the most widely accepted metric to assess whether increases in longevity have been accompanied by a compression of morbidity.

objectiveTo propose a departure from a highly restrictive FL/D-based definition of "morbidity" to a broader view that considers the burden of chronic diseases even when no overt FL/D occur.

designWe outline three reasons why the current framework of compression of morbidity should be broadened to also consider morbidity to be present even when there are no overtly measurable FL/D. We discuss various scenarios of morbidity compression and morbidity expansion under this broader rubric of morbidity.

conclusionThe rationale to go beyond a purely FL/D-based definition of morbidity includes: (1) substantial damage from chronic disease that can develop prior to overt FL/D symptoms occurring; (2) multiple costs to the individual and society that extend beyond FL/D, including medication costs, health care visits, and opportunity costs of lifelong treatment; and (3) psychosocial and stress burden of being labeled as diseased and the consequence for overall well-being. Adopting this broader definition of morbidity suggests that increases in longevity have been possibly accompanied by an expansion of morbidity, in contrast to Fries' original hypothesis that morbidity onset (based on only FL/D) would be delayed to a greater extent than increases in survival. There is an urgent need for better data and more research to document morbidity onset and its link with increases in longevity and assess the important question on whether populations while living longer are also healthier.

Indexed as

MorbidityTerminology as TopicAge FactorsCost of IllnessHealth ServicesHumansLife ExpectancyQuality of LifeTime Factorsagingcompression of morbiditydisabilitymorbidity

Identifiers

PMID25261699
PMCPMC4176669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.